Cargando…

Five tumor-associated autoantibodies expression levels in serum predict lung cancer and associate with poor outcome

BACKGROUND: This study aims to evaluate diagnostic feasibility of the tumor-associated autoantibodies and their clinical significance in lung cancer. METHODS: Blood samples were collected from 352 lung cancer patients and 226 healthy individuals. Immunohistochemical staining was used to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shaolei, Ma, Yuanyuan, Xiong, Ying, Zhang, Panpan, Wang, Xiao, Wang, Yong, Yang, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798311/ https://www.ncbi.nlm.nih.gov/pubmed/35116879 http://dx.doi.org/10.21037/tcr.2019.07.25

Ejemplares similares

BPI-9016M, a c-Met inhibitor, suppresses tumor cell growth, migration and invasion of lung adenocarcinoma via miR203-DKK1
por: Zhang, Panpan, et al.
Publicado: (2018)

Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis
por: Tang, Zhen-Ming, et al.
Publicado: (2017)

circ_0000567/miR-421/TMEM100 Axis Promotes the Migration and Invasion of Lung Adenocarcinoma and Is Associated with Prognosis
por: Hong, Yang, et al.
Publicado: (2022)

CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer
por: Si, Jiahui, et al.
Publicado: (2017)

High serum haptoglobin level is associated with tumor progression and predicts poor prognosis in non-small cell lung cancer
por: Lu, Jianjun, et al.
Publicado: (2016)

Diagnostic value of multiple tumor-associated autoantibodies in lung cancer
por: Zhang, Rui, et al.
Publicado: (2019)

Diagnostic value of α-enolase expression and serum α-enolase autoantibody levels in lung cancer
por: Zhang, Lihong, et al.
Publicado: (2018)

Diagnostic value of tumor-associated autoantibodies panel in combination with traditional tumor markers for lung cancer
por: Xu, Yu, et al.
Publicado: (2023)

Autoantibodies against tumor-associated antigens in sputum as biomarkers for lung cancer
por: Li, Ning, et al.
Publicado: (2020)

Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinoma
por: Li, Yang, et al.
Publicado: (2020)

The association of five preoperative serum tumor markers and pathological features in patients with breast cancer
por: Lian, Mingjian, et al.
Publicado: (2019)

Serum Vaspin Levels Are Associated with the Development of Clinically Manifest Arthritis in Autoantibody-Positive Individuals
por: Maijer, Karen I., et al.
Publicado: (2015)

Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays
por: Yang, Qian, et al.
Publicado: (2020)

A tumor-associated autoantibody panel for the detection of non-small cell lung cancer
por: Cai, Ruijun, et al.
Publicado: (2022)

Low serum ficolin-3 levels are associated with severity and poor outcome in traumatic brain injury
por: Pan, Jian-Wei, et al.
Publicado: (2015)

Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma
por: Ma, Yangcheng, et al.
Publicado: (2022)

Seven tumor‐associated autoantibodies as a serum biomarker for primary screening of early‐stage non‐small cell lung cancer
por: Chen, Ping, et al.
Publicado: (2021)

BARD1 serum autoantibodies for the detection of lung cancer
por: Pilyugin, Maxim, et al.
Publicado: (2017)

Association of serum irisin concentration with thyroid autoantibody positivity and subclinical hypothyroidism
por: Chen, Zhengyi, et al.
Publicado: (2021)

Use of autoantibodies against tumor-associated antigens as serum biomarkers for primary screening of cervical cancer
por: Jin, Yingji, et al.
Publicado: (2017)

The Implication of Serum Autoantibodies in Prognosis of Canine Mammary Tumors
por: Yuan, Stephen Hsien-Chi, et al.
Publicado: (2022)

An Updated Mendelian Randomization Analysis of the Association Between Serum Calcium Levels and the Risk of Alzheimer’s Disease
por: Shi, Yuchen, et al.
Publicado: (2021)

Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties
por: Si, Jiahui, et al.
Publicado: (2019)

Autoantibodies to Tumor-Associated Antigens in Breast Carcinoma
por: Piura, Ettie, et al.
Publicado: (2010)

Tumor-associated autoantibodies as diagnostic and prognostic biomarkers
por: Heo, Chang-Kyu, et al.
Publicado: (2012)

Association of serum follistatin levels with histological types and progression of tumor in human lung cancer
por: Zhang, Pengyu, et al.
Publicado: (2018)

Low early posttransplant serum tacrolimus levels are associated with poor patient survival in lung transplant patients
por: Ryu, Jung-Hwa, et al.
Publicado: (2019)

Sputum Autoantibodies Are More Relevant in Autoimmune Responses in Asthma than Are Serum Autoantibodies
por: Qin, Rundong, et al.
Publicado: (2019)

Tumor mutational burden is associated with poor outcomes in diffuse glioma
por: Wang, Lihong, et al.
Publicado: (2020)

Comparable Autoantibody Serum Levels against Amyloid- and Inflammation-Associated Proteins in Parkinson’s Disease Patients and Controls
por: Maetzler, Walter, et al.
Publicado: (2014)

Serum albumin levels and serum albumin-globulin ratio are associated with poor prognosis in glioblastoma
por: Yalikun, Kugeluke, et al.
Publicado: (2020)

Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients
por: Stanton, Sasha E., et al.
Publicado: (2021)

AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma
por: Zhang, Shusen, et al.
Publicado: (2020)

Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC)
por: Dai, Liping, et al.
Publicado: (2013)

Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma
por: Sun, Yifan, et al.
Publicado: (2017)

Serum Anti-CCNY Autoantibody Is an Independent Prognosis Indicator for Postoperative Patients with Early-Stage Nonsmall-Cell Lung Carcinoma
por: Ma, Li, et al.
Publicado: (2013)

High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma
por: Wang, Hua, et al.
Publicado: (2016)

Autoantibodies to Tumor-Associated Antigens in Epithelial Ovarian Carcinoma
por: Piura, Benjamin, et al.
Publicado: (2009)

MCAM is associated with metastasis and poor prognosis in osteosarcoma by modulating tumor cell migration
por: Du, Xiaotian, et al.
Publicado: (2021)

The presence of autoantibodies is associated with improved overall survival in lung cancer patients
por: Jing, Keying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eapnnqnsc9e0ppf7cgtfb8i6s8